Company profile: 123Compliance
1.1 - Company Overview
Company description
- Provider of compliance-focused solutions for the life science industry, with more than 20 years of experience. As a Salesforce partner, has built and implemented global complaint handling, quality management, regulatory reporting, and document management systems for small and large pharmaceutical and medical device companies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to 123Compliance
Protein Mechanics
HQ: United States
Website
- Description: Provider of cross-disciplinary computational techniques to accelerate drug discovery and design, offering novel methods that enable physically accurate modeling of biomolecular systems at unprecedented speeds, with the aim of making in silico biology an everyday tool for medical researchers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protein Mechanics company profile →
Colwiz
HQ: United Kingdom
Website
- Description: Provider of a free research management, collaboration and productivity platform for individual researchers, groups, departments and organizations, featuring graphing tools. Delivered via web, desktop (Windows, Mac, Linux) and mobile applications synced in real time, it manages the entire research lifecycle from an initial idea.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Colwiz company profile →
Immunetrics
HQ: United States
Website
- Description: Provider of biosimulation solutions for drug discovery and development, including Thales, a QSP model-building platform that automates and streamlines modeling, generates virtual patient populations, and refines designs; QSP modeling and consulting services; clinical trial simulations and optimization; non-inferiority/bioequivalence analysis; and trial power analysis to predict efficacy and optimize clinical trial design.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunetrics company profile →
LabCentral
HQ: United States
Website
- Description: Provider of a facility (LabCentral 238) offering on-site capacities for collaborative cell therapy programs in regenerative medicine and immuno-oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LabCentral company profile →
Matrical
HQ: United States
Website
- Description: Provider of biological sample preparation, management and storage solutions, offering automated biobanking; sample storage systems from ambient to cryogenic; cryogenic storage and carriers; injection-molded microwell plates; a sample management LIMS for biobanking and cell lines; multiomics and synthesis (sequencing, proteomics); and sample storage, relocation and transportation with on-site management, risk mitigation and disaster recovery support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Matrical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for 123Compliance
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to 123Compliance
2.2 - Growth funds investing in similar companies to 123Compliance
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for 123Compliance
4.2 - Public trading comparable groups for 123Compliance
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →